Dr. Gulati has 40 years of experience in medical and pharmaceutical research. Formerly Dean of Research, he is now an Adjunct Professor at the Midwestern University, Illinois. Dr. Gulati is recipient of Outstanding Faculty Award, Paul R Dawson Biotechnology Award and Littlejohn Award. He is a United States Fulbright Scholar and winner of International Ranbaxy Research Award. He has more than 300 peer reviewed publications and guided researches of more than 100 graduate students, medical residents and research fellows. He has 54 issued patents.
Formerly, Union Health Secretary, Government of India. Mr. Verma is a very senior administrator with deep experience in the health sector. He was instrumental in formulating and implementing many policies related to the drug development process in India. He also has remarkable interest in literary work.
Mr. Gulati has more than 35 years of experience in running operations of various companies. He has considerable experience and knowledge in launching companies, getting required regulatory approvals and making the companies fully operational . Along with that, he also has extensive experience in international trade.
Mr. Srimal is a veteran Global Pharmaceutical Business Manager with a demonstrated international track record of product and market development. As top level Executive Officer he had been instrumental in driving revenues and profits.
Dr. Reddy has more than 20 years of experience in the biopharmaceutical industry. He has led research and development of products to market success. He managed preclinical development and clinical pharmacology of 4 USFDA approved products. Has a wide range of experience in drug development, including preclinical development, early clinical development, regulatory strategy, intellectual property strategy and technical diligence for licensing. He is an inventor on 17 US patents and has co-authored over 30 peer-reviewed publications.
Mr. Toft graduated with a classical diploma from Phillips Exeter Academy, an A.B. degree with high honors in economics from Dartmouth College, and an MBA in accounting and finance from the Amos Tuck School of Business Administration. Mr. Toft was a founding Principal of Julian, Toft, & Downey, Inc., prior to its merger with Transwestern Commercial Real Estate Services, Inc., where he was a Managing Director. He has been personally responsible for closing more than $3.0 billion in debt and equity financing.
Dr. Lavhale did his PhD in Pharmaceutical Sciences and worked as Research associate at Midwestern University, USA for about 3 years before joining Pharmazz. He has 11 years of research experience. He has been involved in preclinical and clinical development of pharmaceuticals.
Dr. Varshney is PhD from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. She has worked as postdoctoral fellow at All India Institute of Medical Sciences (AIIMS), New Delhi. Dr. Varshney has worked with medical research journal associated with Indian Council of Medical Research (ICMR), New Delhi. She is having 13 years of experience in medical research. During this period, she has received ICMR, UGC fellowships and research awards.
Mr. Costello brings about 20 years of accounting, budgeting, audit preparation, reporting and financial modeling experience to Pharmazz. He served as Controller for Julian Toft and Downey, Inc. and as Vice President in Transwestern Commercial Real Estate’s Capital Markets Group. Mr. Costello has assisted in the closing of over $500 million in structured finance and equity transactions. Mr. Costello has a CPA designation, earning the Elijah Watts Sells Award for passing with honors, and graduated from Western Illinois University in finance, Magna Cum Laude.
Dr. Andurkar is Professor and Chair of Pharmaceutical Sciences at the Midwestern University Chicago College of Pharmacy. He has pursued a program of research involving the design, synthesis, biological evaluation and metabolism of bioactive molecules for the past 17 years. He has been awarded various Distinctions & Honors like Golden Apple Award, Teacher of the Year, Midwestern University Chicago College of Pharmacy, for many consecutive years. He has to his honor one issued patent.
Dr. Srimal has more than 50 years of leadership, teaching and research experience in Pharmaceutical Institutions. He has been the Director of Indian Institute of Toxicology Research, Lucknow. He is member of National Academy of Medical Sciences and has been a Commonwealth Medical Fellow. He has been consultant to UNIDO, Commonwealth Secretariat and The University of Illinois at Chicago, Chicago, USA.